MSRPS
AZN icon

Maryland State Retirement & Pension System’s AstraZeneca AZN Stock Holding History

Maryland State Retirement & Pension System’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.1M Buy
171,841
+2,251
+1% +$423K 0.55% 38
2026
Q1 		$33M Buy
+169,590
New +$32.7M 0.67% 31

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Maryland State Retirement & Pension System's AZN Position: Q2 2026 in Review

Maryland State Retirement & Pension System increased its AstraZeneca (AZN) stake by 1.3% in Q2 2026, buying an estimated $423K and bringing the position to 171,841 shares worth $32.1M. The position accounts for 0.55% of the portfolio, ranked #38.

Maryland State Retirement & Pension System first reported a position in AZN in Q1 2026 and has held it in 2 quarters since. The position peaked at $33M in Q1 2026. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Maryland State Retirement & Pension System held 171,841 shares of AstraZeneca worth $32.1M as of Q2 2026.
  • Maryland State Retirement & Pension System bought 2,251 AstraZeneca shares in Q2 2026, an estimated $423K.
  • AstraZeneca made up 0.55% of Maryland State Retirement & Pension System's portfolio in Q2 2026, its #38 holding.
  • Maryland State Retirement & Pension System first reported a position in AstraZeneca in Q1 2026 and has held it in 2 quarters since.
  • Maryland State Retirement & Pension System's AstraZeneca position peaked at $33M in Q1 2026.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Maryland State Retirement & Pension System's 13F filing for Q2 2026, filed 30 Jul 2026.